LUMIBIRD Records Q3 Growth and Signs Acquisition Agreement

Lumibird, a leader in laser technologies, reported a 2% revenue increase, reaching €141.5 million in the first nine months of 2024. The third quarter highlighted an 8% growth in the Medical segment while the Photonics segment remained stable. Lumibird also announced an agreement to acquire the Continuum nanosecond laser product line from Amplitude Laser Group, enhancing its scientific market offerings and strengthening its North American presence.

The Photonics division's revenue increased by 2%, driven by demand in Defense/Space and Medtech sectors. However, the Industrial & Scientific sector saw a 15% decline. Meanwhile, the Medical division increased by 8% in Q3, reaching €23.4 million, largely fueled by laser treatments.

Geographically, the Photonics division experienced 20% growth in Europe but faced declines in the Americas and Asia-Pacific. The Medical division saw increased sales in Europe and Asia-Pacific, benefiting from reduced administrative obstacles in China.

The acquisition of Continuum is expected to boost Lumibird’s market share in nanosecond lasers and generate industrial synergies, aligning with its strategy of expanding in recurring markets.